BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16212902)

  • 1. Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia.
    Li W; Fu J; Wang F; Yu G; Wang Y; Zhang X
    Cell Mol Immunol; 2004 Apr; 1(2):142-7. PubMed ID: 16212902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
    Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
    J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ; Anel A; Gamen S; Monle n I; Lasierra P; Larrad L; Piñeiro A; Alava MA; Naval J
    J Immunol; 1999 Aug; 163(3):1274-81. PubMed ID: 10415024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
    Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
    Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells.
    Chen LC; Shyu HW; Chen SH; Lei HY; Yu CK; Yeh TM
    J Med Virol; 2006 Jun; 78(6):780-6. PubMed ID: 16628611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Fas ligand is elevated in T lymphocytes in severe aplastic anaemia.
    Luther-Wyrsch A; Nissen C; Wodnar-Filipowicz A
    Br J Haematol; 2001 Sep; 114(4):884-90. PubMed ID: 11564081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
    Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
    Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas ligand in the uterus of the non-pregnant mouse induces apoptosis of CD4+ T cells.
    Imarai M; Varela-Nallar L; Figueroa-Gaete C; González P; Valdés D; Velásquez L; Cárdenas H; Maisey K
    J Reprod Immunol; 2005 Jun; 66(1):13-32. PubMed ID: 15949559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human primary adenotonsillar naïve phenotype CD45RA CD4 T lymphocytes undergo apoptosis upon stimulation with a high concentration of CD3 antibody.
    Pajusto M; Tarkkanen J; Mattila PS
    Scand J Immunol; 2005 Dec; 62(6):546-51. PubMed ID: 16316422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis.
    De Rose V; Cappello P; Sorbello V; Ceccarini B; Gani F; Bosticardo M; Fassio S; Novelli F
    J Leukoc Biol; 2004 Aug; 76(2):423-32. PubMed ID: 15123769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial ovarian cancer cells secrete functional Fas ligand.
    Abrahams VM; Straszewski SL; Kamsteeg M; Hanczaruk B; Schwartz PE; Rutherford TJ; Mor G
    Cancer Res; 2003 Sep; 63(17):5573-81. PubMed ID: 14500397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse.
    Lettau M; Qian J; Linkermann A; Latreille M; Larose L; Kabelitz D; Janssen O
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5911-6. PubMed ID: 16595635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.